NAPT welcomes CMS rule to improve prior authorization, remains committed to further improving patient access to proton therapy

Press releases may be edited for formatting or style | January 19, 2024 Business Affairs Rad Oncology Proton Therapy

“The announcement by CMS represents a positive step in the direction of streamlining the prior authorization process,” said Dr. Charles Simone, Chief Medical Officer of the New York Proton Center. “While I greatly commend this advancement, it is important to recognize the existing gaps that necessitate further attention. It is crucial to emphasize the significance of ensuring all patients have access to timely prior authorization processes. The ultimate objective remains a streamlined process that unequivocally prioritizes access to cancer care without undue delays.”

About NAPT
The National Association for Proton Therapy (NAPT) is an independent nonprofit organization founded in 1990 to educate and increase awareness about the clinical benefits of proton therapy. Its members include 47 of the nation’s leading cancer centers, many of which are NCI-designated comprehensive cancer centers and NCCN members. The mission of NAPT is to work collaboratively to raise public awareness of the clinical benefits of proton therapy, ensure patient choice and access to affordable proton therapy, and encourage cooperative research and innovation to advance the appropriate and cost-effective utilization of proton therapy.

Back to HCB News

You Must Be Logged In To Post A Comment